Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06800599

Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment

Registro Mono-istituzionale Di Individui Sottoposti a Valutazione Del Rischio Genetico Oncologico

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
7,000 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Single-centre, retrospective, prospective observational cohort study, based on the registration of data from users of the Oncology Genetics Outpatient Clinic

Detailed description

The primary objective of this study is to establish a register to collect and update over time the clinical, genetic and socio-demographic data of all patients who will be assessed for a suspected oncological genetic predisposition, in order to acquire information that can be used for conducting specific studies aimed at clarifying the various uncertainties that still characterise these diseases, such as the clinical significance and the genotype-phenotype correlations of many alterations in oncological predisposition genes oncological predisposition genes, the clinical and bio-pathological features predictive of a significant probability of identifying mutations in these genes, the efficacy of surveillance and prevention measures undertaken to reduce the risk oncological risk according to guidelines, the effectiveness of oncological therapies in patients with hereditary tumours in comparison with those with sporadic neoplasms sporadic neoplasms, risk perception, emotional impact and also interpersonal experiences associated with oncological genetic risk assessment. These are objectives of primary interest to both the patient and public health (given the general frequency of oncological diseases), because the information acquired will make it possible to improve the general clinical management of all cancer patients and their families.

Conditions

Timeline

Start date
2022-05-01
Primary completion
2037-12-31
Completion
2037-12-31
First posted
2025-01-30
Last updated
2025-01-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06800599. Inclusion in this directory is not an endorsement.